Cell and gene therapy commercialization handbook: Key strategies to help address market challenges

Scientific innovation alone won’t get cell and gene therapies to more patients. Manufacturers must overcome unprecedented hurdles in market access, regulatory, distribution, logistics, and patient access. With experience supporting 200+ CGT manufacturers and 30+ FDA/EMA-approved therapies, we’re sharing proven strategies. Download the guide to achieve CGT success.